LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Kotansky, Brian"
  2. AU="Kumaravel, Arthi"
  3. AU="Lordkipanize, David"
  4. AU="Kurzawinski, Tom R"
  5. AU="Wu, Xinwu"
  6. AU="Grijalva, Marcelo"
  7. AU="van Zuylen, Wendy J"
  8. AU="Asarnow, L D"
  9. AU="So, Ronald"
  10. AU="deSouza, Ashwin L"
  11. AU="Härtlova, Anetta"
  12. AU="Ghanem, Ahmed I"
  13. AU="Yue Lu"
  14. AU="Pincus, Laura B"
  15. AU="Ibrahim, Nashwan"
  16. AU=Bray Molly S AU=Bray Molly S
  17. AU="Bregy, Amadé"
  18. AU=Kaper J B
  19. AU="León-Ramón, Susana"
  20. AU="Simpson, Andrew"
  21. AU="Peters, Wibke"
  22. AU="Malik, Sajid Ali"
  23. AU="V, Gomathi"

Suchergebnis

Treffer 1 - 4 von insgesamt 4

Suchoptionen

  1. Artikel ; Online: Clinical outcomes following dalbavancin administration in patients with barriers to outpatient parenteral antimicrobial therapy.

    Tuan, Jessica J / Kayani, Jehanzeb / Fisher, Ann / Kotansky, Brian / Dembry, Louise-Marie / Datta, Rupak

    Antimicrobial stewardship & healthcare epidemiology : ASHE

    2022  Band 2, Heft 1, Seite(n) e83

    Abstract: Between 2016 and 2021, we retrospectively identified 42 patients receiving ≥1 dose of dalbavancin for osteomyelitis, skin and soft-tissue infection, endocarditis or bacteremia, or septic arthritis. Median antibiotic duration prior to dalbavancin ... ...

    Abstract Between 2016 and 2021, we retrospectively identified 42 patients receiving ≥1 dose of dalbavancin for osteomyelitis, skin and soft-tissue infection, endocarditis or bacteremia, or septic arthritis. Median antibiotic duration prior to dalbavancin administration was 7 days. Within 90 days, 93% achieved clinical cure, 12% were readmitted, 12% developed hepatotoxicity, and 5% died.
    Sprache Englisch
    Erscheinungsdatum 2022-05-20
    Erscheinungsland England
    Dokumenttyp Journal Article
    ISSN 2732-494X
    ISSN (online) 2732-494X
    DOI 10.1017/ash.2022.229
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Implementation of a standardized process for outpatient COVID-19 treatments at a Veterans Affairs medical center.

    Kravetz, Jeffrey D / Tarabar, Asim F / Dalton, Robert / Kotansky, Brian / Curtin, Rebecca N

    Journal of the American Pharmacists Association : JAPhA

    2022  Band 62, Heft 6, Seite(n) 1880–1884

    Abstract: Background: The initial availability and distribution of new therapeutic options for outpatients with mild to moderate coronavirus disease 2019 (COVID-19) was limited by insufficient supply, challenges related to administration and dispensing, and ... ...

    Abstract Background: The initial availability and distribution of new therapeutic options for outpatients with mild to moderate coronavirus disease 2019 (COVID-19) was limited by insufficient supply, challenges related to administration and dispensing, and unique clinical considerations of each medication.
    Objective: This study aimed to describe the implementation of a standardized process for prescribing, dispensing, and administering medications for outpatients with mild to moderate COVID-19 infection.
    Methods: Patients evaluated in outpatient clinics, the emergency department, or urgent care locations who tested positive for COVID-19 with mild to moderate symptoms were candidates for outpatient management. An interdisciplinary team involving physicians from primary care and the emergency department, pharmacists, and nursing developed a standardized note template to gather relevant information before initiating outpatient COVID-19 treatment. Pharmacists reviewed the patients' eligibility for treatment and discussed the available options with providers to facilitate the timely provision of appropriate treatment.
    Results: A total of 134 outpatients were evaluated for COVID-19 treatment from January 10, 2022, to March 10, 2022. Following a retrospective chart review, it was determined that a medication was administered or dispensed to 80 of those patients.
    Conclusion: Collaboration as an interdisciplinary team allowed for the efficient development of a systematic process in which outpatients with COVID-19 could be evaluated, prescribed, and administered appropriate medications to reduce their risk of disease progression.
    Mesh-Begriff(e) Humans ; COVID-19/drug therapy ; Outpatients ; Veterans ; Retrospective Studies ; Ambulatory Care
    Sprache Englisch
    Erscheinungsdatum 2022-06-25
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 2118585-2
    ISSN 1544-3450 ; 1544-3191 ; 1086-5802
    ISSN (online) 1544-3450
    ISSN 1544-3191 ; 1086-5802
    DOI 10.1016/j.japh.2022.06.010
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Clinical Utility of On-Demand Multiplex Respiratory Pathogen Testing among Adult Outpatients.

    Green, Daniel A / Hitoaliaj, Letiana / Kotansky, Brian / Campbell, Sheldon M / Peaper, David R

    Journal of clinical microbiology

    2016  Band 54, Heft 12, Seite(n) 2950–2955

    Abstract: Multiplex tests for respiratory tract infections include up to 20 targets for common pathogens, predominantly viruses. A specific therapeutic intervention is available for individuals testing positive for influenza viruses (oseltamivir), and it is ... ...

    Abstract Multiplex tests for respiratory tract infections include up to 20 targets for common pathogens, predominantly viruses. A specific therapeutic intervention is available for individuals testing positive for influenza viruses (oseltamivir), and it is potentially beneficial to identify non-influenza viruses to avoid unnecessary antibiotic use. We evaluated antimicrobial prescriptions following respiratory pathogen testing among outpatients at a large Veterans Administration (VA) medical center. Results of the FilmArray respiratory panel (BioFire, Salt Lake City, UT) from 15 December 2014 to 15 April 2015 were evaluated among 408 outpatients, and patient medical records were reviewed. Differences in antibiotic and oseltamivir prescription rates were analyzed. Among 408 patients tested in outpatient centers (emergency departments, urgent care clinics, and outpatient clinics), 295 (72.3%) were managed as outpatients. Among these 295 outpatients, 105 (35.6%) tested positive for influenza virus, 109 (36.9%) tested positive for a non-influenza virus pathogen, and 81 (27.5%) had no respiratory pathogen detected. Rates of oseltamivir and antibiotic prescriptions were significantly different among the three test groups (chi-squared values of 167.6 [P < 0.0001] and 10.48 [P = 0.005], respectively), but there was no significant difference in antibiotic prescription rates between the non-influenza virus pathogen group and those who tested negative (chi-square value, 0; P = 1.0). Among adult outpatients, testing positive for influenza virus was associated with receiving fewer antibiotic prescriptions, but no such effect was seen for those who tested positive for a non-influenza virus. These data suggest that testing for influenza viruses alone may be sufficient and more cost-effective than multiplex pathogen testing for outpatients.
    Mesh-Begriff(e) Adult ; Aged ; Aged, 80 and over ; Ambulatory Care Facilities/statistics & numerical data ; Anti-Bacterial Agents/therapeutic use ; Asthma/diagnosis ; Emergency Service, Hospital/statistics & numerical data ; Female ; Humans ; Influenza, Human/diagnosis ; Influenza, Human/drug therapy ; Male ; Middle Aged ; Orthomyxoviridae/isolation & purification ; Oseltamivir/therapeutic use ; Practice Patterns, Physicians'/statistics & numerical data ; Pulmonary Disease, Chronic Obstructive/diagnosis ; Respiratory Tract Infections/diagnosis ; Respiratory Tract Infections/virology ; Retrospective Studies
    Chemische Substanzen Anti-Bacterial Agents ; Oseltamivir (20O93L6F9H)
    Schlagwörter covid19
    Sprache Englisch
    Erscheinungsdatum 2016-12
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 390499-4
    ISSN 1098-660X ; 0095-1137
    ISSN (online) 1098-660X
    ISSN 0095-1137
    DOI 10.1128/JCM.01579-16
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel: 2018 American Society of Consultant Pharmacists Annual Meeting & Exhibition.

    Bridgeman, Mary / Prete, Donna / Rolston, Nicole / Abazia, Daniel / Sturgill, Marc / Finn, Laura / Summers, Deborah / Marvanova, Marketa / Henkel, Paul / Thompson, Jayson / Dewey, Mark / Friesner, Daniel / Alessi, Carolyn / Cuellar, Lourdes / Yamagishi, Lisa / O'Neil, Christine / Erickson, Olivia / Mazzei, Kelly / Kamal, Khalid /
    Early, Nicole / Bainter, Brian / Hanson, Laura / Schmitz, Emily / Loomis, Amanda / Norberto, Marissa / Hume, Anne / Meyer, Marsha / Batra, Romilla / Likar, Denise / Enguidanos, Susan / Liu, Catherine / Kotansky, Brian / Fisher, Ann / Ruby, Christine M / Pruskowski, Jennifer / Karim, Siti Nurhana Abdul / Yong, Belinda Soon Wei / Slattum, Patricia / Crouse, Ericka / Delafuente, Jeffrey / Donohoe, Krista / Ogbonna, Kelechi / Peron, Emily / Powers, Kacie / Price, Elvin / Zimmerman, Kristin / Rahim, Sarah / Gendron, Tracey / Cho, Clarissa / Elliott, Lindsay / Minter, Candace / Morin, Mary / Marshall, Leisa / Stevens, Gregg / Cordaro, Charles / Hill, Matthew / Nagy, Kayla / Kroustos, Kelly Reilly / Sobota, Kristen Finley / Mahan, Rebecca / Bailey, Trista / Ioannou, Kara / Mansour, Diana / Thompson, Tristan / Chatellier, Kristel / Schwenk, Amanda / Ruby, Christine / Chen, Tsuhua Susan / Li, Shilun / James, Marian / Spilios, Maria / Leschak, Andrea / Levine, Alexander / Forgette, Stephanie / Oluigbo, Nneka / Szollosi, Doreen / Avalime, Dzifa / Weaver, Salome Bwayo / Maneno, Mary / Ettienne, Earl / Yi, Julia Yunkyung / Hart, Laura / Gray, Shelly / Ozalas, Stephanie / Miller, Kayla / Dave, Rohini / Bork, Jacqueline / Emmelhainz, Janetta / Adams, Kaylee / Postolski, Joshua / Willoughby, Matthew / Feldman, Elizabeth / Braham, Kelly / Miller, Christopher / Barbagallo, Deena / Seabury, Robert / Noviasky, John / Dabhi, Jayvir / Bartlett, Donna / Le, Tham / Simoni-Wastila, Linda / Kuzucan, Aida / Park, Siyeon / Choi, Michelle / Khokhar, Bilal / Brody, Peter / Hejna, Mary / Mason, Jessica / Graham, Miranda / Micceri, Jessica / Lypska, Roksolana / Quinn, Bryan / Wilson, Henry / Wahler, Robert / Aloyo, Marissa / Tomm, Vanessa / Hill, Angela / Obringer, Alan / Butterfoss, Kirsten / Blak, Julia / Balcer, Rebecca / Boza, Jenna / Foster, Amanda / Shafique, Ehtesham / Kleven, Casondra / Wigle, Patricia / Brown, Bethanne / Meyer, Kristin / Mobley-Bukstein, Wendy / Singh, Hemlata / Perez, Emelia / Mira, Alaa-Eldin / Kuehner, William / Czechowski, Lou / Cook, Heather / Brandt, Nicole / Parson, Janee / Fornaro, Rachyl / Claeys, Kimberly / Zarowitz, Barbara / Mansour, Daniel / McFadden, Chelsea / Simpkins, Sierra / Ojowa, Folarin / Klutts, Abigail / Holmes, Sarah / Smith, Everett / Cornman, Jr Reba / Doran, Kelly / Resnick, Barbara / Umeozulu, Chinasa / Williams, Anne / Hennawi, George / Thomas, Danielle / Gerber, Dawn Knudsen / Sharma, Kriti / Cooke, Catherine / Howard, Amy / Chater, Rebecca / Vogler, Abbie / Kennett-Hayes, Kaitlyn / Elliott, Laura / Engelbert, John / Hargrave, Emily / Bambico, Chynna / Patel, Kripali / Warriner, Cynthia / Desai, Nihar R / Rowan, Christopher G / Alvarez, Paula / Fogli, Jeanene / Toto, Robert D / Reed, Pamala / Owens, Mary Kay / Greden, John F / Rothschild, Anthony J / Zandy, Shannon / Thase, Michael / Dunlop, Boadie W / DeBattista, Charles / Conway, Charles R / Forester, Brent P / Mondimore, Francis M / Shelton, Richard C / Li, James / Gilbert, Alexa / Burns, Lindsey / Jablonski, Michael / Dechairo, Bryan / Parikh, Sagar / Donohue, James / Feldman, Gregory / Sethi, Sanjay / Barnes, Chris / Pendyala, Srikanth / Bourdet, David / Ferguson, Gary / Crater, Glenn / Mayo, Martha / Gross, Coleman / Miyawa, John / Ono, Reyn / Woods, Steven / Garza, Dahlia / Panov, Natalie / Moran, Edmund / Sabesan, Vijay / Wertman, James / Ngim, Kenley

    The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists

    2018  Band 33, Heft 10, Seite(n) 572–608

    Abstract: Poster abstracts are evaluated based on the following criteria: significance of the problem to healthy aging or medication management; innovativeness of ideas, methods, and/or approach; methodological rigor of methods and approach; presentation of ... ...

    Abstract Poster abstracts are evaluated based on the following criteria: significance of the problem to healthy aging or medication management; innovativeness of ideas, methods, and/or approach; methodological rigor of methods and approach; presentation of finding; implications identified for future research, practice, and/or policy; and clarity of writing. Submissions are not evaluated through the peer-reviewed process used by
    Sprache Englisch
    Erscheinungsdatum 2018-10-15
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 1107921-6
    ISSN 2331-0936 ; 0888-5109
    ISSN (online) 2331-0936
    ISSN 0888-5109
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang